IPG to keep pay reductions for top executives for rest of 2020
WPP and Publicis have ended COVID salary cuts.
News
Herd Immunity 101: Explaining vaccination effectiveness to patients
Detailing the importance of immunization and clarifying the concept of herd immunity to patients is a worthwhile conversation at any time but especially relevant in the COVID-19 era, rife with an abundance of information and misinformation.
Stalled HHS coronavirus ad campaign sought to capitalize on star power, but public-health push came too late
The Department of Health and Human Services drafted public health officials and celebs to push a “defeat despair” message. But if this qualifies as an embrace of science, it’s too late.
2020 Career and Salary Survey: Is COVID responsible for the 12% drop in average salary?
Respondents to the annual MM+M/AbelsonTaylor Career and Salary Survey report a 12% drop in average salary in 2020. Whether that’s attributable to COVID-19 or a sign of darker days to come is anybody’s guess.
Five things for pharma marketers to know: Monday, October 19, 2020
More than 25% of state legislators have accepted campaign contributions from pharma since 2019; Pfizer won’t seek emergency authorization of COVID vaccine until late Nov.; Study: Remdesivir failed to prevent deaths from virus.
“Accountability matters:” A Q&A with Meredith research SVP Britta Cleveland
Three years after the venerable publisher debuted its Pharma Lift Guarantee, Cleveland discusses its impact and print’s continued appeal to pharma marketers.
AbelsonTaylor’s Jay Carter unpacks the Career and Salary Survey results
Jay Carter is EVP and director of business development at AbelsonTaylor.
Arthur Sadoun on out-performing rivals, ending salary cuts and a second COVID wave
Publicis chief talks to Campaign after better than expected Q3.
Five things for pharma marketers to know: Friday, October 16, 2020
Ebola therapy approved by FDA for first time; Oxford scientists develop COVID-19 test that detects virus in five minutes; WHO: Lockdown should be last resort for handling COVID-19 outbreaks.
The Escalator: Jesse Kates returns to Neon as co-managing director
Plus, people moves at Woebot Health and SPI Pharma.
Want to read more?
Please login or register first to view this content.
